Clinical Trial Update: A Study of GZR18 Injection in Obese/Overweight Patients [Phase 2]

View source ↗

Summary

Phase 2 trial of GZR18 Injection in obese/overweight participants has completed, reporting results from a United States study sponsored by Gan and Lee Pharmaceu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• GZR18 Injection

Snippet

Sponsor: Gan and Lee Pharmaceuticals, USA | Conditions: Obesity, Overweight | Phase 2 | Status: COMPLETED